Edwards Lifesciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.

CEO

Bernard J. Zovighian

CEOBernard J. Zovighian

Employees

15,800

Employees15,800

Headquarters

Irvine, California

HeadquartersIrvine, California

Founded

1958

Founded1958

Employees

15,800

Employees15,800

EW Key Statistics

Market cap

44.24B

Market cap44.24B

Price-Earnings ratio

30.71

Price-Earnings ratio30.71

Dividend yield

—

Dividend yield—

Average volume

5.20M

Average volume5.20M

High today

$76.60

High today$76.60

Low today

$74.94

Low today$74.94

Open price

$76.10

Open price$76.10

Volume

5.00M

Volume5.00M

52 Week high

$95.25

52 Week high$95.25

52 Week low

$58.93

52 Week low$58.93

EW News

TipRanks 3d

Edwards Lifesciences Reports Robust Q1 2025 Growth

Edwards Lifesciences Corp. ((EW)) has held its Q1 earnings call. Read on for the main highlights of the call. In the recent earnings call, Edwards Lifesciences...

Benzinga 5d

Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens

Edwards Lifesciences‘ EW shares are trading higher Thursday after the company reported first-quarter 2025 sales of $1.41 billion. That’s almost in line with th...

Simply Wall St 5d

Edwards Lifesciences Projects 2025 Sales Over US$5.7 Billion With Strong Earnings

recently announced its updated guidance, projecting second-quarter 2025 sales between $1.45 billion and $1.53 billion, alongside first-quarter results showing a...

Analyst ratings

50%

of 32 ratings

Buy

50%

Hold

46.9%

Sell

3.1%

More EW News

TipRanks 5d

Edwards Lifesciences price target raised to $75 from $72 at Baird

Baird raised the firm’s price target on Edwards Lifesciences (EW) to $75 from $72 and keeps a Neutral rating on the shares. The firm updated its model following...

TipRanks 5d

Edwards Lifesciences: Hold Rating Amid Strong Q1 Results and Future Challenges

TD Cowen analyst Josh Jennings has maintained their neutral stance on EW stock, giving a Hold rating on April 16. Josh Jennings has given his Hold rating due t...